From Casetext: Smarter Legal Research

In re NPS Pharms., Inc.

United States Court of Appeals for the Federal Circuit
Nov 15, 2017
2017-1392 (Fed. Cir. Nov. 15, 2017)

Opinion

2017-1392 2017-1393

11-15-2017

IN RE: NPS PHARMACEUTICALS, INC., Appellant

JOSEPH R. ROBINSON, Troutman Sanders LLP, New York, NY, argued for appellant. Also represented by ROBERT SCHAFFER; DUSTIN B. WEEKS, Atlanta, GA.


NOTE: This disposition is nonprecedential. Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2015-00990, IPR2015-01093.

JUDGMENT

JOSEPH R. ROBINSON, Troutman Sanders LLP, New York, NY, argued for appellant. Also represented by ROBERT SCHAFFER; DUSTIN B. WEEKS, Atlanta, GA. THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (PROST, Chief Judge, DYK and CHEN, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT November 15, 2017

Date

/s/ Peter R. Marksteiner

Peter R. Marksteiner

Clerk of Court


Summaries of

In re NPS Pharms., Inc.

United States Court of Appeals for the Federal Circuit
Nov 15, 2017
2017-1392 (Fed. Cir. Nov. 15, 2017)
Case details for

In re NPS Pharms., Inc.

Case Details

Full title:IN RE: NPS PHARMACEUTICALS, INC., Appellant

Court:United States Court of Appeals for the Federal Circuit

Date published: Nov 15, 2017

Citations

2017-1392 (Fed. Cir. Nov. 15, 2017)